ABOUT SUVODA
Suvoda is a global clinical trial technology company whose real-time experience platform empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com. Follow Suvoda on LinkedIn.
-
Suvoda And Greenphire Announce Completion of Merger
Suvoda and Greenphire have announced the successful completion of their previously announced merger. Through this merger, the combined company is now better equipped to provide a comprehensive solution to its customers to support the urgent and mission critical moments of their clinical trials.
FEATURED ARTICLES
-
Accurate quality of life data is critical in oncology. eCOA unified with IRT streamlines trials, improves data collection, and enhances site user experiences across therapeutic areas.
-
Real-time eCOA data enables faster eligibility decisions, proactive issue alerts, and streamlined operations by unifying data, improving precision, responsiveness, and trial execution efficiency.
-
Clinical trials don’t have to be so complex. Jagath Wanninayake shares why focusing on time-sensitive moments—and not everything at once—can drive better outcomes and how a recent merger supports that shift.
-
Discover how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.
-
Speed up trial launches and maintain predictable timelines by leveraging a modern, integrated approach to eCOA setup that reduces complexity.
-
Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.
-
Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.
-
Running a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.
-
Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.
-
Simplifying participation honors patient altruism, improves engagement, and strengthens the quality of trial data, ultimately advancing medical innovation.
-
Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.
-
If you're ready to streamline your clinical trials and deliver better outcomes for all stakeholders, explore how the Suvoda Platform can transform your trial experience today.
-
The clinical trial landscape is undergoing a transformative shift as technology increasingly shapes study design and execution. Explore three pivotal trends that are driving this evolution.
-
Now is the time to evaluate your current risk management framework. Take action today to strengthen your safeguards, tailor your risk assessments, and prioritize transparent patient engagement.
-
The World Medical Association (WMA) has announced a significant, rare update to its cornerstone ethical document, the Declaration of Helsinki, which guides medical research involving human participants.
CONTACT INFORMATION
Suvoda
181 Washington St., Suite 100
Conshohocken, PA 19428
UNITED STATES
OUR PRODUCTS
ADDITIONAL PRODUCT INFORMATION
NEWS
- Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence
- Suvoda And Greenphire Announce Completion of Merger
- Greenphire Launches Industry's First Patient Experience Dataset Transforming Clinical Trial Planning And Providing A View Into The Patient Journey
- Greenphire Announces Acquisition Of Clincierge To Enhance Clinical Trial Support Services
- Greenphire And Florence Healthcare Announce Technology Partnership
- Greenphire Launches GreenSpace App And Expands Global Payment Functionality
- Greenphire Appoints Steve Geffon As Chief Commercial Officer
- Greenphire Expands Agreement With Merck To Help Reduce Financial And Travel Barriers For Clinical Trial Participants Worldwide
- Greenphire Selected To Address Patient Engagement And Recruitment, Diversity, And Other Vital Clinical Trial Issues At Leading Industry Events
- Greenphire Announces Strategic Growth Investment From Thoma Bravo